Omalizumab Retreatment of Patients swith Chronic Idopathic Urticaria/Spontaneous Urticaria (CIU/CSU) Following Return of Symptoms: Primary Results of the OPTIMA Study

Main Article Content

Gordon Sussman
Jacques Hebert
Wayne Gulliver
Charles Lynde
William H Yang
Olivier Chambenoit
Antonio Vieira
Frederica De Takacsy
Lenka Rihakova

Keywords

urticaria, omalizumab, chronic urticaria, biologic therapy

Abstract

Abstract Not Available